PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
ORKA Oruka Therapeutics
- 11.180
- -0.250-2.19%
Close Feb 14 16:00 ET
- 11.180
- 0.0000.00%
Post 20:01 ET
391.28MMarket Cap-29.42P/E (TTM)
11.905High10.830Low248.88KVolume11.170Open11.430Pre Close2.80MTurnover1.06%Turnover RatioLossP/E (Static)35.00MShares33.00052wk High1.15P/B261.68MFloat Cap10.19752wk Low--Dividend TTM23.41MShs Float40838092.445Historical High--Div YieldTTM9.41%Amplitude10.068Historical Low11.246Avg Price1Lot Size
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025
Oruka Therapeutics Stock Forum
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
Half-life in non-human primates (NHP) of 30.3 days after subcutaneous (SQ) administration and 33.8 days after intravenous (IV) administration
Equivalent potency to risankizumab with similar binding affinity and epitope demonstrated in several preclinical assays
MENLO PARK, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc...
looking forward to see how this performs
No comment yet